VPI-AMIKACIN
VPI-AMIKACIN
Dormant
DIN Number
02506599
Drug Class
Human
Market Date
Jan 25, 2021
Company
HC
VPI Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02506599
AIG Number0111922001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01GB06 AMIKACIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification08:12.02
Health Canada Classification
ACTIVE INGREDIENTS (1)
AMIKACIN (AMIKACIN SULFATE)Active
Strength: 500 MG / 2 ML
Monograph: AMIKACIN (AMIKACIN SULFATE)